The largest database of trusted experimental protocols

4 protocols using pyrrolidine dithiocarbamate

1

Investigating HPSE and NF-κB Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary antibodies for HPSE (latent precursor: 65 kDa, active HPSE: 50 kDa), GAPDH, and isotype IgG were purchased from Santa Cruz (Dallas, Texas, USA); the primary antibodies for lamin B1, NF-κB p65, IκBα, and IκBα pSer32 from Cell Signaling Technology (Danvers, Massachusetts, USA); a primary antibody for heparan sulfate proteoglycan was purchased from Bioss (Woburn, Massachusetts, USA); blocking antibodies against TLR1 (GD2.F4), TLR2 (TL2.1), and TLR4 (HTA125) from eBioscience (San Diego, CA, USA); a blocking antibody against TLR6 (TLR6.127) from Abcam (Cambridge, UK); a mouse Histone H4 ELISA kit was purchased from USCN Life Science (Wuhan, China); a mouse HPSE ELISA kit was purchased from Biorbyt (Cambridge, UK). A blocking antibody against Histone H4 (anti-H4) was prepared following the previously described protocol [15 (link)]. Histone H4 was purchased from Millipore (Billerica, MA, USA); and the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) was obtained from Abcam (Waltham, MA, USA). All other reagents were purchased from Sigma (St. Louis, MO, USA), unless stated otherwise.
+ Open protocol
+ Expand
2

Curcumin Modulates NF-κB Pathway in Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Curcumin and collagenase II were obtained from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany) and a 10 mM stock solution was prepared in dimethyl sulfoxide, and diluted with cell culture medium immediately prior to use.
Cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco; ThermoFisher Scientific, Inc.) and 100 IU/ml penicillin, 100 mg/ml streptomycin at 37°C in a humidified atmosphere of 95% air and 5% CO2.
Recombinant human IL-1β was supplied by PeproTech, Inc. (Rocky Hill, NJ, USA). Primary antibodies against type II collagen (AB746) and MMP-13 (AB39012) were purchased from Abcam (Cambridge, UK). Primary antibodies against NF-κB inhibitor α (IκBα; 4814S), phosphorylated (p)-IκBα (9246S) and NF-κB p65/RelA (8242S) were provided by Cell Signaling Technology, Inc. (Danvers, MA, USA). The selective NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC), primary antibodies against GAPDH (AB8245) and lamin B1 (AB16048), and horseradish peroxidase (HRP)-conjugated secondary antibody (AB7097) were obtained from Abcam. Cell culture reagents were purchased from Gibco (Thermo Fisher Scientific, Inc.).
+ Open protocol
+ Expand
3

Regulation of VEGF and HMGB1 Release

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Western blot analysis20 (link), unconcentrated CM was separated on 10% SDS-PAGE gel and probed for VEGF and HMGB1. Band densitometry was normalized to protein levels of the source Mϕs and expressed relative to levels in air-CM. HUVEC lysates were analyzed for eNOS and phosphorylated eNOS (P-eNOS) while Mϕ lysates were analyzed for inducible NO synthase (iNOS), IκB, STAT3, P-STAT3 and GAPDH. Mϕ were treated with the NFκB inhibitor pyrrolidine dithiocarbamate (50μmol/L; PDTC, Abcam) or STAT3 inhibitor S3I-201(100μmol/L; Santa Cruz) to determine the effect these transcriptional factors on VEGF and HMGB1 release.
+ Open protocol
+ Expand
4

Mechanical Allodynia Assessment and Pharmacological Interventions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mechanical allodynia was assessed by measuring mechanical withdrawal threshold values using an electronic von Frey filament (no.38450; UGO Basile, Varese, Italy). Rats were individually placed in an acrylic cage and habituated for 10 minutes. The filament was vertically applied to the planta skin of the left hind paw, and force values were measured until the animal exhibited withdrawal or licking of the hind paw. The measurements were performed seven times in 2- to 3-min intervals, and averaged data were collected, omitting the maximum and minimum values. All of the von Frey tests were assessed by a researcher who was blind to the experimental groups. For drug injections, URB597 (0.3 mg/kg, Cayman Chemical, Ann Arbor, MI, US) and PDTC (pyrrolidine dithiocarbamate, 200 mg/kg, Abcam, Cambridge, UK) were administered intraperitoneally daily for 3 days after the induction of CPIP. Additionally, hydralazine was administered at 2 mL/kg for 3 days, which constituted a dose of 25 mg/kg of hydralazine. Nocifensive behavior was tested before drug injection and at 5 days post initial injection. During the 5 days, each drug was injected on days 0–2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!